Memantine for Agitation and Aggression in Severe Alzheimer's Disease

This study has been completed.

Sponsor:

Collaborator:

Lundbeck Canada Inc.

Information provided by (Responsible Party):

Sunnybrook Health Sciences Centre

ClinicalTrials.gov Identifier:

NCT00401167

First received: November 16, 2006

Last updated: May 24, 2012

Last verified: January 2010

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	January 2010
Primary Completion Date:	January 2010 (Final data collection date for primary outcome measure)

No publications provided by Sunnybrook Health Sciences Centre

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Herrmann N, Cappell J, Eryavec GM, Lanctôt KL. Changes in nursing burden following memantine for agitation and aggression in long-term care residents with moderate to severe Alzheimer's disease: an open-label pilot study. CNS Drugs. 2011 May 1;25(5):425-33.

To Top